CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CREX • US22530J3095

3.2 USD
0 (0%)
Last: Feb 4, 2026, 04:30 PM
Fundamental Rating

2

Taking everything into account, CREX scores 2 out of 10 in our fundamental rating. CREX was compared to 91 industry peers in the Media industry. Both the profitability and financial health of CREX have multiple concerns. While showing a medium growth rate, CREX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year CREX was profitable.
  • CREX had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
  • In multiple years CREX reported negative operating cash flow during the last 5 years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

  • CREX has a worse Return On Assets (-14.93%) than 65.93% of its industry peers.
  • CREX's Return On Equity of -41.80% is in line compared to the rest of the industry. CREX outperforms 41.76% of its industry peers.
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • The Gross Margin of CREX (43.13%) is comparable to the rest of the industry.
  • CREX's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CREX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

  • CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CREX has more shares outstanding than it did 1 year ago.
  • CREX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CREX has a worse debt to assets ratio.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -0.43, we must say that CREX is in the distress zone and has some risk of bankruptcy.
  • CREX has a Altman-Z score of -0.43. This is in the lower half of the industry: CREX underperforms 68.13% of its industry peers.
  • CREX has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
  • CREX's Debt to Equity ratio of 1.01 is in line compared to the rest of the industry. CREX outperforms 50.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z -0.43
ROIC/WACCN/A
WACC7.71%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that CREX should not have too much problems paying its short term obligations.
  • The Current ratio of CREX (1.03) is comparable to the rest of the industry.
  • A Quick Ratio of 0.77 indicates that CREX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.77, CREX is not doing good in the industry: 67.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

  • The earnings per share for CREX have decreased by 0.00% in the last year.
  • Looking at the last year, CREX shows a very negative growth in Revenue. The Revenue has decreased by -18.37% in the last year.
  • The Revenue has been growing by 9.98% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

  • Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 66.98% on average per year.
  • CREX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.68% yearly.
EPS Next Y-91.64%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.86 indicates a rather expensive valuation of CREX.
  • Based on the Price/Earnings ratio, CREX is valued a bit cheaper than the industry average as 70.33% of the companies are valued more expensively.
  • CREX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 12.30, the valuation of CREX can be described as correct.
  • 69.23% of the companies in the same industry are more expensive than CREX, based on the Price/Forward Earnings ratio.
  • CREX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.51.
Industry RankSector Rank
PE 22.86
Fwd PE 12.3
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CREX indicates a slightly more expensive valuation: CREX is more expensive than 62.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 113.74
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • CREX's earnings are expected to grow with 66.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for CREX!.
Industry RankSector Rank
Dividend Yield 0%

CREATIVE REALITIES INC

NASDAQ:CREX (2/4/2026, 4:30:00 PM)

3.2

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12
Earnings (Next)03-12
Inst Owners15%
Inst Owner Change0.22%
Ins Owners12.48%
Ins Owner Change0%
Market Cap33.66M
Revenue(TTM)44.32M
Net Income(TTM)-9.15M
Analysts84
Price Target8.29 (159.06%)
Short Float %1.23%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.19%
Min EPS beat(2)-149.99%
Max EPS beat(2)-82.4%
EPS beat(4)1
Avg EPS beat(4)57.24%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-6.96%
Max Revenue beat(2)6.23%
Revenue beat(4)2
Avg Revenue beat(4)-2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-2.2%
Revenue beat(12)4
Avg Revenue beat(12)-4.14%
Revenue beat(16)4
Avg Revenue beat(16)-3.48%
PT rev (1m)0%
PT rev (3m)22.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-333.33%
EPS NY rev (1m)3.13%
EPS NY rev (3m)-616.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)41.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.72%
Valuation
Industry RankSector Rank
PE 22.86
Fwd PE 12.3
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 1.54
P/tB N/A
EV/EBITDA 113.74
EPS(TTM)0.14
EY4.38%
EPS(NY)0.26
Fwd EY8.13%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS4.21
BVpS2.08
TBVpS-1.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.56
Profitability
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score2
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 46.08
Cap/Depr 51.44%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z -0.43
F-Score2
WACC7.71%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y-91.64%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-219.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.05%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-208.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.48%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 2 / 10 to CREX.


Can you provide the valuation status for CREATIVE REALITIES INC?

ChartMill assigns a valuation rating of 3 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Overvalued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


What are the PE and PB ratios of CREATIVE REALITIES INC (CREX) stock?

The Price/Earnings (PE) ratio for CREATIVE REALITIES INC (CREX) is 22.86 and the Price/Book (PB) ratio is 1.54.